Protalix BioTherapeutics Inc (PLX)

3.77 -0.15  -3.83% NYSE AM Jan 23, 16:59 Real time USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
03/13/2020 08:30 EDT Misc Protalix BioTherapeutics Inc Fourth Quarter Earnings Conference Call in 2019
03/13/2020 Earnings Protalix BioTherapeutics Inc Fourth Quarter Earnings in 2019 Release
12/20/2019 Splits Ratio: 1:10
11/07/2019 08:30 EST Misc Protalix BioTherapeutics Inc Third Quarter Earnings Conference Call for 2019
11/07/2019 Earnings Protalix BioTherapeutics Inc Third Quarter Earnings in 2019 Release
08/08/2019 08:30 EDT Misc Protalix BioTherapeutics Inc Second Quarter Earnings Conference Call in 2019
08/08/2019 Earnings Protalix BioTherapeutics Inc Second Quarter Earnings in 2019 Release
05/30/2019 13:00 IST Misc Protalix BioTherapeutics Inc Annual General Meeting in 2018
05/06/2019 08:30 EDT Misc Protalix BioTherapeutics Inc First Quarter Earnings Conference Call in 2019
05/06/2019 Earnings Protalix BioTherapeutics Inc First Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.protalix.com
  • Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=101161&p=irol-IRHome
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Mar. 13, 2020
  • Last Earnings Release: Nov. 07, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa, for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. Its pipeline products include Alidornase Alfa, Pegunigalsidase Alfa, and Oprx-106. The company's primary sources of revenues include its sales of taliglucerase alfa in Brazil and of drug substance to Pfizer under its Amended Pfizer Agreement.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.